A 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP of the European Pharmacopoeia monograph is often referred to as a 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 Certificate of Suitability (COS). The purpose of a 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 to their clients by showing that a 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP has been issued for it. The manufacturer submits a 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP (COS) as part of the market authorization procedure, and it takes on the role of a 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP holder for the record. Additionally, the data presented in the 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 DMF.
A 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133 suppliers with CEP (COS) on PharmaCompass.